SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-23-011490
Filing Date
2023-02-14
Accepted
2023-02-14 16:01:15
Documents
2
Group Members
BML GENERAL PARTNER LTDROSETTA CAPITAL LTD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea173546-13ga1rosetta1_for.htm SC 13G/A 99639
2 JOINT FILING AGREEMENT DATED AS OF FEBRUARY 14, 2023, BY AND AMONG EACH OF THE R ea173546ex99-1_forward.htm EX-99.1 5581
  Complete submission text file 0001213900-23-011490.txt   106731
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Subject) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88394 | Film No.: 23628496
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEW BROAD STREET HOUSE 35 LONDON X0 EC2M 1NH
Business Address NEW BROAD STREET HOUSE 35 LONDON X0 EC2M 1NH 44 0 20 7194 8080
Rosetta Capital I, LP (Filed by) CIK: 0001633682 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A